Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023595 · ClinicalTrials.gov registry record · Phase 3
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
A Phase 3 study of Cardiovascular Diseases and Heart Diseases, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,136
- Enrollment target
- 1
- Study location
NCT00023595: Completed Phase 3 study of Cardiovascular Diseases and Heart Diseases, sponsored by Duke University.
NCT00023595 is a Phase 3 study of Cardiovascular Diseases and Heart Diseases that has completed, run by Duke University. The registered enrollment target is 2,136 participants, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023595, a Phase 3 study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,136 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare medical therapy with coronary bypass surgery and/or surgical ventricular reconstruction for patients with congestive heart failure and coronary artery disease (CAD).
Conditions Studied
Interventions
- PROCEDURE CABG surgery plus MED
- DRUG Active Medication Alone
- PROCEDURE CABG plus MED and SVR
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,136 participants |
| Start Date | 2002-01 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
What the finished NCT00023595 record still lists
NCT00023595 is an interventional study that assigns participants to a tested intervention. Its 2,136 participants enrollment target places it among the larger protocols in the corpus, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower).
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which CABG surgery plus MED is the first listed.
NCT00023595 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00023595 about?
NCT00023595 is a clinical study titled "Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease". This study will compare medical therapy with coronary bypass surgery and/or surgical ventricular reconstruction for patients with congestive heart failure and coronary artery disease (CAD).
What is the current status of trial NCT00023595?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,136 participants. The study started on 2002-01. Estimated completion is 2015-11.
What conditions does trial NCT00023595 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Heart Failure, Congestive, Coronary Disease.
What interventions are being tested in trial NCT00023595?
The interventions under investigation include: CABG surgery plus MED (PROCEDURE), Active Medication Alone (DRUG), CABG plus MED and SVR (PROCEDURE).
Who is sponsoring clinical trial NCT00023595?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00023595 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00023595's enrollment target sits among peer trials
2,136 36th of 300 higher than 265 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RECRUITING · Phase 3
-
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of Hematocrit Levels in Infant Heart Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia